Skip to Content

Join the 'Jalyn' group to help and get support from people like you.

Jalyn News

Drug May Ease Passage When Kidney Stone Strikes

Posted 29 Jul 2015 by Drugs.com

WEDNESDAY, July 29, 2015 – Kidney stones can quickly cause extreme pain, and passing the stones is the immediate goal for patients. Now, a new study finds that the drug tamsulosin (Flomax) can boost the passage of large kidney stones, but not small ones. "Small stones usually pass on their own, so it's not too surprising that drug therapy did not help in this study," said Dr. Warren Bromberg, chief of urology at Northern Westchester Hospital in Mt. Kisco, N.Y. On the other hand, "anything that assists in passing a large stone, which otherwise would lead to prolonged pain and surgical intervention, is well worth it," said Bromberg, who was not involved in the new research. The study was led by Jeremy Furyk of Townsville Hospital in Queensland, Australia. His team found that 28 days after visiting an emergency department for any size of kidney stone, 87 percent of patients treated with ... Read more

Related support groups: Flomax, Tamsulosin, Jalyn, Dutasteride/tamsulosin, Calcium Oxalate Calculi with Hyperuricosuria

FDA OKs Impotence Drug Cialis to Treat Enlarged Prostate

Posted 7 Oct 2011 by Drugs.com

THURSDAY, Oct. 6 – The U.S. Food and Drug Administration announced late Thursday that it had approved using the erectile dysfunction drug Cialis as a treatment for enlarged prostate. According to the U.S. National Institutes of Health, enlarged prostate – clinically known as benign prostatic hyperplasia (BPH) – is a "common part of aging" for men. In fact, the NIH estimates that "more than half of men in their 60s, and as many as 90 percent in their 70s and 80s, have some symptoms of BPH." The condition often leads to urinary incontinence and can raise the odds for urinary tract infections and even kidney damage. "BPH can have a big impact on a patient's quality of life," Scott Monroe, director of the division of reproductive and urologic products in the FDA's Center for Drug Evaluation and Research, said in an agency news release. "A large number of older men have symptoms of BPH. ... Read more

Related support groups: Erectile Dysfunction, Cialis, Benign Prostatic Hyperplasia (BPH), Flomax, Urinary Incontinence, Avodart, Rapaflo, Cardura, Jalyn, Proscar, Uroxatral, Hytrin

Accidental Medication Poisonings in Kids on the Rise

Posted 16 Sep 2011 by Drugs.com

FRIDAY, Sept. 16 – Despite ongoing prevention efforts, a growing number of young children are being accidentally poisoned with medications, according to new research. The study, which was based on data reported to the American Association of Poison Control Centers between 2001 and 2008, found that medication poisoning among children aged 5 and under increased by 22 percent, although the number of children in the United States in this age group rose by only 8 percent during the study period. "The problem of pediatric poisoning in the U.S. is getting worse, not better," Dr. Randall Bond, of Cincinnati Children's Hospital Medical Center, said in a hospital news release. In conducting the study, which is scheduled for publication in the Journal of Pediatrics, the researchers reviewed information on over 544,000 children who landed in the emergency department due to medication poisoning ... Read more

Related support groups: Xanax, Suboxone, Oxycodone, Hydrocodone, Methadone, Percocet, OxyContin, Klonopin, Vicodin, Lisinopril, Norco, Fentanyl, Clonazepam, Morphine, Ativan, Ambien, Valium, Codeine, Metoprolol, Lortab

Drugs for Enlarged Prostate May Raise Risk of Aggressive Cancer

Posted 9 Jun 2011 by Drugs.com

THURSDAY, June 9 – The U.S. Food and Drug Administration is calling for new warning labels on a class of drugs used primarily to treat enlarged prostates, because the medications may raise the risk of developing an aggressive form of prostate cancer. In a statement released Thursday, the agency said the drugs involved include popular medications sold under the brand names Proscar and Propecia (sold by Merck & Co.) and Avodart and Jalyn (sold by GlaxoSmithKline). According to the FDA, almost 5 million men were prescribed one of these medications between 2002 and 2009. Of these, nearly 3 million men were between the ages of 50 and 79. The agency is advising doctors not to start patients on these drugs until prostate cancer – which can mimic the symptoms of an enlarged prostate – and other urological conditions have been ruled out. According to the agency, this new warning is based on ... Read more

Related support groups: Avodart, Finasteride, Propecia, Jalyn, Proscar, Dutasteride, Dutasteride/tamsulosin

FDA Medwatch Alert: 5-alpha reductase inhibitors (5-ARIs): Label Change - Increased Risk of Prostate Cancer

Posted 9 Jun 2011 by Drugs.com

Drugs in the 5-ARI class include finasteride and dutasteride. These drugs are marketed under the brand-names Proscar, Propecia, Avodart, and Jalyn ISSUE: FDA notified healthcare professionals that the Warnings and Precautions section of the labels for the 5-alpha reductase inhibitor (5-ARI) class of drugs has been revised to include new safety information about the increased risk of being diagnosed with a more serious form of prostate cancer (high-grade prostate cancer). BACKGROUND: The new safety information is based on FDA’s review of two large, randomized controlled trials––the Prostate Cancer Prevention Trial (PCPT) and the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial. Proscar, Avodart, and Jalyn are approved to improve symptoms of an enlarged prostate gland (benign prostatic hyperplasia or BPH). Proscar and Avodart are also approved to reduce the risk of urina ... Read more

Related support groups: Avodart, Finasteride, Propecia, Jalyn, Proscar, Dutasteride, Dutasteride/tamsulosin

Ask a Question

Further Information

Related Condition Support Groups

Benign Prostatic Hyperplasia (BPH)

Jalyn Patient Information at Drugs.com